Skip to content

A study to see effect of manjisthadi lepa in treatment of hyperpigmentation.

A Single Arm Open Label Clinical Trial To Assess The Efficacy Of Manjisthadi Lepa In The Management Of Vyanga

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/023698
Enrollment
30
Registered
2020-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Manjisthadi lepa(Manjisthadi,Vasa,Arjuntwak): To be applied daily in the morning for 30 mins with honey.Duration of the study is for 30 days(0-15th day-30th day) Control Intervention1:

Sponsors

Dr Jai Bhawani Babulal Barai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having signs and symptoms of vyanga

Exclusion criteria

Exclusion criteria: Hyperpigmentation caused by tumour like malingant melanoma. Patients with secondary systemic involvement. Vyanga along with kustha roga will be excluded. Pregnant and lactating women. Hyperpigmentation caused since birth is excluded because prognosis is very bad in these conditions.

Design outcomes

Primary

MeasureTime frame
To get cured of Hyperpigmentation.Timepoint: The cure shall be assessed by two follow ups in 30 days.

Secondary

MeasureTime frame
Getting cured of the marked symptoms on the skin adding to the cosmetic effect.Timepoint: 30 days

Countries

India

Contacts

Public ContactDr Jai Bhawani Babulal Barai

Dr.D.Y Patil College Of Ayurveda and Research Institute

gunvantayurved@gmail.com9028321955

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026